Talphera (TLPH) Total Current Liabilities (2010 - 2026)
Talphera's (TLPH) quarterly Total Current Liabilities came in at $4.0 million in Q1 2026, up 102.36% year-on-year from $2.0 million in Q1 2025, and up 5.67% quarter-over-quarter from $3.8 million in Q4 2025.
Talphera (TLPH) Total Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 102.36% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 102.36% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 43.9% from the prior year.
- Total Current Liabilities advanced to $4.0 million in Q1 2026 per TLPH's latest filing, from $3.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $17.7 million in Q2 2022 and bottomed at $2.0 million in Q1 2025.
- The 5-year median for Total Current Liabilities is $3.8 million (2025), against an average of $6.7 million.
- Across the five-year window, Total Current Liabilities plunged 77.16% in 2023 and surged 102.36% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $13.8 million in 2022, then plunged by 67.23% to $4.5 million in 2023, then slumped by 41.33% to $2.6 million in 2024, then surged by 43.9% to $3.8 million in 2025, then advanced by 5.67% to $4.0 million in 2026.
- Per Business Quant, the three latest TLPH Total Current Liabilities figures stand at $4.0 million (Q1 2026), $3.8 million (Q4 2025), and $3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 3.21 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 9.46 Mn |
| Dec 31, 2022 | 13.77 Mn |
| Sep 30, 2022 | 15.65 Mn |
| Jun 30, 2022 | 17.69 Mn |
| Mar 31, 2022 | 17.03 Mn |
| Dec 31, 2021 | 18.51 Mn |
| Sep 30, 2021 | 17.07 Mn |
| Jun 30, 2021 | 15.19 Mn |